Summary
Measurements of biliary lipid secretion rates were performed in 14 non-obese patients with radiolucent gallstones (9 females, 5 males; mean age 48 years; mean body weight 65 kg) and in 14 healthy male volunteers (mean age 26 years, mean body weight 74 kg). The results in the gallstone patients differ in several respect from those obtained in the volunteers. Molar percentage of cholesterol was higher (5.8 versus 5.0 mol%;P<0.05) and molar percentage of bile acids lower (73.8 versus 76.9 mol%;P<0.05) in the gallstone patients. However, these changes were not followed by notable differences in cholesterol saturation of bile (94% vs 88%). Generally, hepatic secretion rates of cholesterol were significantly elevated in the gallstone patients (55 vs 46 mg/h;P<0.05) whereas outputs of bile acids and phospholipids did not differ between the two groups. Although patients with cholesterol gallstones tended to have a lower percentage of chenodeoxycholic acid (38 versus 42 mol%) and increased deoxycholic acid (23 versus 16 mol%) in their bile, these differences were not significant. Nevertheless, in patients with cholesterol gallstones a significant positive correlation between deoxycholic acid secretion and cholesterol output was observed. For the whole group of patients and volunteers a positive correlation between age and cholesterol secretion could be demonstrated. The higher hepatic cholesterol secretion in gallstone patients seems not be due to differences in body weight, but rather to the older age of the patients. These results suggest that age itself or age-related changes in deoxycholic acid metabolism contributes to biliary cholesterol output in non-obese patients with cholesterol gallstones.
Similar content being viewed by others
Abbreviations
- CA:
-
cholic acid
- CDCA:
-
chenodeoxycholic acid
- DCA:
-
deoxycholic acid
References
Admirand WH, Small DM (1968) The physicochemical basis of cholesterol gallstone formation in man. J Clin Invest 47:1043–1052
Bartlett GR (1959) Phosphorous assay in column chromatography. J Biol Chem 234:466–468
Bateson MC, Maclean D, Ross PE, Bouchier IAD (1978) Clofibrate therapy and gallstone induction. Digestive Diseases 23:623–628
Bennion LJ, Grundy SM (1975) Effects of obesity and caloric intake on biliary lipid metabolism in man. J Clin Invest 56:996–1011
Bennion LJ, Grundy SM (1978) Risk factors for the development of cholelithiasis in man. N Engl J Med 299:1161–1167, 1221–1227
Bennion LJ, Mott DM, Howard BV (1980) Oral contraceptives raise the cholesterol saturation of bile by incresing biliary cholesterol secretion. Metabolism 29:18–22
Boston Collaborative Drug Surveillance Programme (1973) Oral contraceptives and venous thromboembolic disease, surgically confirmed gallbladder diesease, and breast tumors. Lancet I:1399–1404
Boston Collaborative Drug Surveillance Programme (1974) Surgically confirmed gallbladder disease, venous thromboembolic disease, and breast tumors in relation to post-menopausal estrogen therapy. New Engl J Med 290:15–19
Carulli N, Ponz de Leon M, Zironi F, Iori R, Loria P (1980) Bile-acid feeding and hepatic sterol metabolism: effect of deoxycholic acid. Gastroenterology 79:637–641
Coronary Drug Project Research Group (1977) Gallbladder disease as a side effect of drugs influencing lipid metabolism: Experience in the Coronary Drug Project. N Engl J Med 296:1185–1190
Einarsson K, Nilsell K, Leijd B, Angelin B (1985) Influence of age on secretion of cholesterol and synthesis of bile acids by the liver. N Engl J Med 313:277–282
Everson GT, Lawson MJ, McKinley C, Showalter R, Kern F Jr (1983) Gallbladder and small intestinal regulation of biliary lipid secretion during intraduodenal infusion of standard stimuli. J Clin Invest 71:596–603
Grundy SM, Ahrens EH jr, Salen G, Schreibman PH, Nestel PJ (1972) Mechanisms of action of clofibrate on cholesterol metabolism in patients with hyperlipidemia. J Lipid Res 13:531–551
Grundy SM, Metzger AL (1972) A physiological method for estimation of hepatic secretion of biliary lipids in man. Gastroenterology 62:1200–1217
Hegardt FG, Dam H (1971) The solubility of cholesterol in aqueous solutions of bile salts and lecithin. Z Ernährungswiss 10:223–233
Hofmann AF, Grundy SM, Lachin JM, Lan S-P, Baum RA, Hanson RF, Hesh T, Hightower NC, Marks JW, Mekhjian T, Shaefer RA, Soloway RD, Thistle JL, Thomas FB, Tyor MP and the National Cooperative Gallstone Study Group (1982) Pretreatment biliary lipid composition in white patients with radiolucent gallstones in the National Cooperative Gallstone Study. Gastroenterology 83:738–752
Holzbach RT, Marsh M, Olszewski M, Holan K (1973) Cholesterol solubility in bile. Evidence that supersaturated bile is frequent in healthy man. J Clin Invest 52:1467–1479
La Russo NF, Szczepanik PA, Hofmann AF (1977) Effect of deoxycholic acid ingestion on bile acid metabolism and biliary lipid secretion in normal subjects. Gastroenterology 72:132–140
Leiss O, von Bergmann K, Gnasso A, Augustin J (1985) Effect of gemfibrozil on biliary lipid metabolism in normolipemic subjects. Metabolism 34:74–82
Leiss O, von Bergmann K, Streicher U, Strotkoetter H (1984) Effect of three different dihydroxy bile acids on intestinal cholesterol absorption in normal volunteers. Gastroenterology 87:144–149
Low-Beer TS, Pomare EW (1975) Can colonic bacterial metabolites predispose to cholesterol gall stones? Br Med J 1:438–440
Mok HYI, von Bergmann K, Grundy SM (1979) Effects of continuous and intermittend feeding on biliary lipid outputs in man: application for measurements of intestinal absorption of cholesterol and bile acids. J Lipid Res 20:389–398
Northfield TC, Hofmann AF (1975) Biliary lipid output during three meals and overnight fast. I. Relationship to bile acid pool size and cholesterol saturation of bile in gallstone and control subjects. Gut 16:1–17
Paumgartner G, Horak W, Probst P, Grabner G (1971) Effect of phenobarbital on bile flow and bile salt excretion in the rat. Naunyn-Schmiedeberg's Arch Pharmakol 270:98–102
Pomare EW, Heaton KW (1973) Alteration of bile salt metabolism by dietary fibre (bran). Br Med J 4:262–264
Report from the Committee of Principal Investigators (1978) A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Br Heart J 40:1069–1118
Shaffer EA, Small DM (1977) Biliary lipid secretion in cholesterol gallstone disease. J Clin Invest 59:828–840
Tarpila S, Miettinen TA, Metsaeranta L (1978) Effects of bran on serum cholesterol, faecal mass, fat, bile acids and neutral sterols, and biliary lipids in patients with diverticular disease of the colon. Gut 19:137–141
Thornton JR, Heaton KW (1981) Do colonic bacteria contribute to cholesterol gall-stone formation? Effects of lactulose on bile. Br Med J 282:1018–1020
van der Werf SDJ, Huiibregts AWM, Lamers HLM, van Berge Hengouwen GP, van Tongeren JHM (1981) Age dependent differences in human bile acid metabolism and 7a-dehydroxylation. Eur J Clin Invest 11:425–431
von Bergmann K, Epple-Gutsfeld M, Leiss O (1984) Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones. Gastroenterology 87:136–143
von Bergmann K, Leiss O (1984) Effect of short-term treatment with bezafibrate and fenofibrate on biliary lipid metabolism in patients with hyperlipoproteinaemia. Eur J Clin Invest 14:150–154
Author information
Authors and Affiliations
Additional information
Dedicated to Professor Dr. Hans J. Dengler on the occasion of his 60th birthday
Rights and permissions
About this article
Cite this article
Leiß, O., von Bergmann, K. Comparison of biliary lipid secretion in non-obese cholesterol gallstone patients with normal, young, male volunteers. Klin Wochenschr 63, 1163–1169 (1985). https://doi.org/10.1007/BF01740592
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01740592